Infinium Pharmachem Limited

₹275.05As of Sun 8 Nov 2026, 12:00 UTC
NSE:INFINIUMHealthcare
Country India
PE (Fwd) •••
TSR 4Y CAGR 32.47%
Div yield —
ROE 10.79%
Medical (Pharmaceuticals)
Beta (5Y) 0.38
PE TTM 35.28
TSR TTM 3.79%
Mkt cap ₹4.286B
ROIC 11.87%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹355
29.04%
(40.47%)
Hold 8|9|2|6|1
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
4.23
4.35
4.20
4.16
34.33%
27.61%
19.84%
6.31%
Revenue₹M
385.5
378.5
381.6
370.2
11.95%
7.44%
6.07%
(2.78%)
Peers (US$45.63M)
Cap (US$)
PE
14.80M
9.350x
45.64M
144.1x
Capital
TTM
5Y
10Y
Leveragex
1.321
2.824
2.417
EBIT/Intx
1.400
0.043
0.056
Own earn%
(124.29)
(108.70)
(43.65)
Sh yield%
49.52
31.71
30.35
Owners
Insiders/Inst%
6.79
23.49
Short interest%
0.69
SBC / revenue%
5.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
30–35
$1 testx
0.0
Incr. ROIC%
0